Altasciences Preclinical Drug Development Solutions

With over 25 years of experience conducting safety assessment, Altasciences offers a full range of in vivo GLP and non-GLP preclinical studies in multiple species to thoroughly assess the safety profile of your molecules. Working as an extension of your team, our scientists and technicians help you expedite your research goals, ensuring that your preclinical drug development program provides the quality data for key decision making.

Our preclinical drug development offerings feature rigorous attention to your needs, including data integrity, scientific excellence, and a strong focus on animal welfare. Our solutions include IND-enabling and NDA-enabling toxicology, safety pharmacology, and laboratory services that meet global regulatory requirements, for both small and large molecules. Our preclinical and clinical services work hand in hand to ensure a rapid and smooth transition from safety testing to first-in-human trials.

Consult our:

  • 210KSQ.‑FT. PURPOSE-BUILT FACILITY
  • 2400+ safety studies completed to date
  • 250+ TEAM MEMBERS

OUR PRECLINICAL DRUG DEVELOPMENT CLIENTS

We serve a wide range of clients from multiple sectors, including:

  • Pharmaceuticals
  • Biologics
  • Vaccines
  • Nucleic acid therapies
  • Animal health products